Magnesium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulphate ## Overview Magnesium sulfate is an essential mineral that plays a vital role in numerous biochemical reactions. It is available in intravenous (IV) and intramuscular (IM) formulations, as well as oral forms. ## Primary Indications * **Hypomagnesemia:** Treatment of low magnesium levels. * **Eclampsia/Preeclampsia:** Prevention and treatment of seizures in pregnant individuals with severe preeclampsia or eclampsia. * **Torsades de Pointes:** Treatment of this specific type of ventricular tachycardia. * **Status Asthmaticus:** Adjunctive therapy in severe asthma exacerbations. ## Adult Dosing * **Hypomagnesemia:** * **Severe Deficiency:** Typically 4-6 grams IV in divided doses over 24 hours. A common regimen is 1 gram IV every 4-6 hours for 4 doses. * **Less Severe Deficiency:** 1-2 grams IV or IM in a single dose, or 2-4 grams IM in divided doses daily. * **Eclampsia/Preeclampsia:** Loading dose of 4-6 grams IV over 5 minutes, followed by a maintenance infusion of 1-2 grams per hour. Local protocols may vary. * **Torsades de Pointes:** 1-2 grams IV in 10 mL of D5W over 5-10 minutes. Repeat doses may be given if necessary. * **Status Asthmaticus:** 1-2 grams IV diluted in 50-100 mL of saline over 15-20 minutes. ## Pediatric Dosing * **Hypomagnesemia:** Dosing is highly variable and depends on the severity of deficiency and patient weight. Common IV dose range: 25-50 mg/kg per dose, not to exceed 2 grams per dose, infused over 1-2 hours. May be repeated every 4-12 hours. * **Eclampsia/Preeclampsia:** Not typically used routinely in pediatric patients. Consult specialized resources and guidelines. * **Status Asthmaticus:** 25-50 mg/kg IV, maximum 2 grams, infused over 15-20 minutes. ## Dose Adjustments No specific dose adjustment is routinely recommended for hepatic impairment. However, caution is advised in renal impairment, as magnesium is renally excreted. Reduce dose and monitor magnesium levels closely. ## Contraindications * **Hypermagnesemia:** Elevated serum magnesium levels. * **Heart Block:** Second or third-degree heart block without a functioning cardiac pacemaker. * **Myocardial Infarction:** Marked myocardial damage. * **Hypersensitivity:** Known hypersensitivity to magnesium sulfate. ## Adverse Effects * **Cardiovascular:** Hypotension, flushing, electrocardiographic changes (e.g., prolonged PR, QRS, and QT intervals), cardiac arrest. * **Neuromuscular:** Drowsiness, decreased reflexes, muscle weakness, respiratory depression, coma. * **Gastrointestinal:** Nausea, vomiting, diarrhea (oral form). * **Other:** Warmth, sweating, hypothermia. ## Key Drug Interactions * **Neuromuscular Blocking Agents:** May potentiate neuromuscular blockade, leading to prolonged respiratory depression. * **Calcium Salts:** May antagonize the effects of magnesium. * **Nifedipine:** Increased risk of hypotension. * **Tetracyclines and Bisphosphonates:** Oral magnesium can decrease absorption; separate administration by several hours. ## Monitoring * **Serum Magnesium Levels:** Essential, especially with repeated dosing or in renal impairment. Target levels vary by indication. * **Renal Function:** Monitor creatinine and urine output, particularly in patients with known or suspected renal insufficiency. * **Vital Signs:** Blood pressure, heart rate, respiratory rate. * **Deep Tendon Reflexes:** Loss of reflexes can indicate magnesium toxicity. * **Electrocardiogram (ECG):** Especially in patients receiving high doses or with cardiac history. ## Clinical Pearls * Magnesium sulfate is a CNS depressant and vasodilator. * IV administration should be slow to avoid hypotension and flushing. * Magnesium toxicity can be reversed with intravenous calcium gluconate. * In eclampsia, continue magnesium sulfate for at least 24 hours postpartum or until 24 hours after the last seizure, whichever is longer. * Oral magnesium sulfate can cause diarrhea. *** *Disclaimer: This information is intended for clinical pharmacists and healthcare professionals. Always consult the most current official prescribing information and institutional protocols for complete and up-to-date guidance.*